Ahmed A Raslan PhD
Research Assistant Professor, Medicine
72 East Concord Street | (617) 358-3928araslan@bu.edu
Biography
My multi-disciplinary academic training and research experience (11 years) have provided me with an excellent background in biology including molecular biology, genetics, cell signaling, and stem cell biology. I got Ph.D. from Soonchunhyang University, S. Korea under the supervision of Dr.Jeong Kyo Yoon. I do research in Stem Cell Biology, Genetics, and Molecular Biology. Now I am a Postdoctoral Associate in Dr.Ligresti's Lab at the Department of Medicine, Boston University School of Medicine, Boston, MA, USA. My Current research work is focusing on understanding the role of endothelial cells in the homeostasis and regeneration of adult lung and during the development of chronic lung disease especially idiopathic pulmonary fibrosis (IPF).
Education
Biomedical Sciences, PhD, Soonchunhyang University
Zoology, BS, Assiut University
Publications
Narota A, Muvavarirwa T, Qiu X, Chakraborty A, Raslan AA, Ligresti G, Trojanowska M. Lymphatic ERG Governs Junctional Plasticity and Fluid Clearance via an EDNRB Signaling Axis in Pulmonary Fibrosis. bioRxiv. 2026 Sep 23. PMID: 42818166.
Published on 8/28/2026Kontodimas K, Raslan AA, Spira B, Zhu C, Karapurkar J, Kefella Y, Chiu D, Qiu X, Beane JE, Ligresti G, Varelas X. LATS1/2 inactivation drives a distinct venous endothelial cell response that contributes to fibrotic remodeling of the lung. Sci Adv. 2026 Aug 28; 12(35):eaef8468. PMID: 42664350.
Published on 8/3/2026Kontodimas K, Raslan AA, Spira B, Chu U, Narota A, Murata H, Hashimoto Y, Nicosia RF, Qiu X, Huang SK, Trojanowska M, Varelas X, Ligresti G. ACKR1-expressing venous endothelial cells establish a pro-fibrotic niche in pulmonary fibrosis. bioRxiv. 2026 Aug 03. PMID: 42620057.
Published on 7/8/2026Grifno GN, Kahvecioglu HA, LeBourdais R, Travnik V, Banerji R, Wangsrikhun W, Shi L, Bozal SB, Suh H, Raslan AA, Batgidis A, Kang B, Deng F, Dalton C, Tsao A, Castle L, Regan K, Kobayter A, Vannini M, Rashidian M, Hao L, Ligresti G, Mizgerd JP, Longest W, Hindle M, Saltzman WM, Butler JP, Suki B, Nia HT. Real-time single-particle imaging of functional lungs reveals mosaic-like patterns of aerosol deposition in alveoli. Nat Biomed Eng. 2026 Jul 08. PMID: 42420427.
Published on 5/28/2026Muscato G, Roos BB, Harris S, Cai XT, Civettini G, Sciacca E, Raslan AA, Castaldi A, Elliot S, Glassberg MK, Vancheri C, Tschumperlin DJ, Ligresti G, Caporarello N. miR-205-5p drives endothelial dysfunction and senescence in pulmonary fibrosis. JCI Insight. 2026 Jul 08; 11(13). PMID: 42207587.
Published on 4/16/2026Antar SA, Mensah E, Dahlka J, Renton MC, Raslan AA, Aziz M, Halouani A, Imani S, Parashar A, Johnstone SR, Benezra R, Fraidenraich D, Ligresti G, Sassi Y. Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis. Theranostics. 2026; 16(11):6081-6098. PMID: 42094605.
Published on 1/1/2026Elsayed FM, Baban J, Elkholy HY, Alwaseef MAE, Omar A, Emam L, Nassef MAM, Morsy MH, Hassanein N, Seada BFAA, Sokkar MHYM, Rezk AA, Akef A, Zeidan MAK, Ali HF, Abumohammed N, DA A, Mohammed SE, Sayed MH, Mahmoud GM, Raslan A, Elmorsy WA, Saad AAEA, Saleh RM, Sadek SA. CAR-T Cell Therapy Versus Salvage Chemotherapy in Relapsed/Refractory DLBCL: A Systematic Review and Meta-Analysis Integrating Radiologic, Laboratory, and Histopathologic Correlates. Clin Ter. 2026; 177(4):887-902. PMID: 42340791.
Published on 10/14/2025Grifno GN, Kahvecioglu HA, LeBourdais R, Travnik V, Banerji R, Wangsrikhun W, Shi L, Bozal SB, Suh H, Raslan AA, Batgidis A, Kang B, Deng F, Dalton C, Tsao A, Castle L, Regan K, Kobayter A, Vannini M, Rashidian M, Hao L, Ligresti G, Mizgerd JP, Longest W, Hindle M, Saltzman WM, Butler JP, Suki B, Nia HT. Mosaic pattern: lung functional heterogeneity at the alveolus level. bioRxiv. 2025 Oct 14. PMID: 41279987.
Published on 7/26/2025Antar SA, Mensah E, Dahlka J, Aziz M, Halouani A, Imani S, Parashar A, Raslan AA, Benezra R, Fraidenraich D, Ligresti G, Sassi Y. A Simultaneous Inhibition of ID1 and ID3 Protects Against Pulmonary Fibrosis. bioRxiv. 2025 Jul 26. PMID: 40777426.
Published on 6/1/2025Hong J, Pham TX, Lee J, Raslan AA, Nicolas K, Sharov A, Meridew JA, Urrutia RA, Lomberk G, Huang SK, Ligresti G. Targeting the Epigenetic Regulator CBX5 Promotes Fibroblast Metabolic Reprogramming and Inhibits Lung Fibrosis. Am J Respir Cell Mol Biol. 2025 Jun; 72(6):627-642. PMID: 39642371.